The BD Ultra-Fine(TM) Pen Needles are designed for enhanced comfort, reduced pain and easier injections.
BD Ultra-FineTM 4mm Pen Needles with EasyFlowTM Technology for faster, more comfortable injections1*#
This product is currently available in Australia (not New Zealand)
The combination of EasyFlow™ Technology and BD’s patented 5-bevel needle tip improves the injection experience for people with diabetes.1,2*#. The flatter, thinner needle tip eases into the skin with up to 23 percent less force and is clinically demonstrated to make injections more comfortable.2#
BD’s shortest, thinnest Ultra-Fine™ 4mm pen needle is suitable for most people with diabetes including adults, children, and those who are overweight.3,4 Used with the appropriate injection technique, the BD Ultra-Fine™ 4mm Pen Needle with EasyFlow™ Technology ensures medication is injected to the correct skin depth over 99.5 percent of the time, at all injection sites .5
Compared to longer pen needles, a 4mm pen needle significantly lowers the risk of injecting diabetes medication into your muscle at all injection sites.3^ Inadvertently injecting medication into a muscle can affect how your medication works and may lead to changes in your blood glucose levels.3
The BD Ultra-Fine™ 4mm Pen Needle with EasyFlow™ Technology also helps make life easier for people who have arthritis or hand strength issues.1* With up to 62 percent less thumb force required to dispense medication, the BD Ultra-Fine™ 4mm Pen Needle with EasyFlow™ Technology has been proven to result in faster injections.1*
Talk to your diabetes healthcare professional today about upgrading to the BD Ultra-Fine™ 4mm Pen Needle with EasyFlow™ Technology for a more comfortable injection experience.1,2
Consumers should consult their diabetes Healthcare Professional regarding treatment of their Diabetes.
* Compared to standard BD thin wall pen needles.
# Compared to standard BD 3-bevel pen needles.
^ Compared to pen needles 5mm, 6mm, 8mm, and 12.7mm in length (95% CI, p<1.001).
- Aronson R. Diabetes Technol Ther. 2012; 14(8): 741-747.
- Hirsch L, Gibney M, Berube J, Manocchio J. J Diabetes Sci Technol. 2012; 6(2): 328-335.
- Frid AH, Kreugel G, Grassi G et al. Mayo Clin Proc. September 2016:91(9):1231-1255.
- Bergenstal R, Strock E, Peremislov D et al. Mayo Clin Proc. March 2015; 90(3):329-338.
- Gibney M, Arce C, Byron K, et al. Curr Med Res Opin. 2010; 26(6): 1519-1530.
Always read the label and follow the directions for use.